薯蓣皂苷在恶性肿瘤中的作用及分子机制研究进展
Research Progress on the Role and Molecular Mechanisms of Dioscin in Malignant Tumors
DOI: 10.12677/acm.2025.1572133, PDF,    科研立项经费支持
作者: 俞 红:丽水市中心医院麻醉科复苏室,浙江 丽水;黄旭华:浙江大学医学院附属第一医院普胸外科,浙江 杭州;曾庆辉, 郑春辉, 章方彪, 赵 纯*:丽水市中心医院心胸外科,浙江 丽水;李淑玲:丽水市中心医院手术室,浙江 丽水
关键词: 薯蓣皂苷恶性肿瘤抗肿瘤机制信号通路联合治疗Dioscin Malignant Tumor Antitumor Mechanism Signaling Pathways Combination Therapy
摘要: 薯蓣皂苷作为一种天然活性成分,近年来在恶性肿瘤治疗领域展现出重要的研究价值和应用潜力。恶性肿瘤是全球范围内威胁人类健康的主要疾病之一,而传统治疗手段如化疗和放疗往往伴随严重的副作用,因此开发高效低毒的新型抗肿瘤药物成为研究热点。薯蓣皂苷通过多种机制发挥抗肿瘤作用,包括抑制肿瘤细胞增殖、诱导凋亡、抑制侵袭转移以及调节免疫微环境等。研究表明,薯蓣皂苷能够靶向调控多条信号通路,从而影响肿瘤的发生发展。然而,目前关于薯蓣皂苷的具体作用靶点和分子机制仍存在许多未解之谜,其在临床转化中的应用也面临挑战。本文系统综述了薯蓣皂苷在多种恶性肿瘤中的抗肿瘤效应及其分子机制,并探讨了其在临床前研究中的应用前景及可能的联合治疗策略,以期为薯蓣皂苷的进一步研究和临床开发提供理论支持。
Abstract: Dioscin, a natural bioactive compound, has recently attracted increasing attention for its potential therapeutic value and application prospects in the treatment of malignant tumors. Malignant tumors remain one of the leading global threats to human health, and conventional therapies such as chemotherapy and radiotherapy are often associated with severe adverse effects. Thus, the development of novel anticancer agents with high efficacy and low toxicity has become a research focus. Dioscin exhibits antitumor effects through multiple mechanisms, including inhibition of tumor cell proliferation, induction of apoptosis, suppression of invasion and metastasis, and modulation of the tumor immune microenvironment. Studies have demonstrated that dioscin can target and regulate various signaling pathways involved in tumorigenesis and cancer progression. However, the specific molecular targets and detailed mechanisms of action of dioscin remain incompletely understood, and its clinical translation still faces several challenges. This review systematically summarizes the antitumor activities and underlying molecular mechanisms of dioscin across various types of malignancies. Furthermore, it discusses the potential of dioscin in preclinical studies and explores possible strategies for combination therapy, aiming to provide theoretical support for further investigation and clinical development of dioscin.
文章引用:俞红, 黄旭华, 曾庆辉, 郑春辉, 李淑玲, 章方彪, 赵纯. 薯蓣皂苷在恶性肿瘤中的作用及分子机制研究进展[J]. 临床医学进展, 2025, 15(7): 1341-1349. https://doi.org/10.12677/acm.2025.1572133

参考文献

[1] Wang, M., Zhang, Y., Ni, S., Sun, M., Wu, Q., Wu, X., et al. (2025) The Anti-Cancer Activity of Dioscin: An Update and Future Perspective. Medical Oncology, 42, Article No. 63. [Google Scholar] [CrossRef] [PubMed]
[2] Lu, D., Yuan, L., Wang, Z., Xu, D., Meng, F., Jia, S., et al. (2025) Dioscin Induces Ferroptosis to Suppress the Metastasis of Gastric Cancer through the SLC7A11/GPX4 Axis. Free Radical Research, 59, 426-441. [Google Scholar] [CrossRef] [PubMed]
[3] Xi, P., Niu, Y., Zhang, Y., Li, W., Gao, F., Gu, W., et al. (2022) The Mechanism of Dioscin Preventing Lung Cancer Based on Network Pharmacology and Experimental Validation. Journal of Ethnopharmacology, 292, Article ID: 115138. [Google Scholar] [CrossRef] [PubMed]
[4] Wu, Z., Han, X., Tan, G., Zhu, Q., Chen, H., Xia, Y., et al. (2020) Dioscin Inhibited Glycolysis and Induced Cell Apoptosis in Colorectal Cancer via Promoting C-Myc Ubiquitination and Subsequent Hexokinase-2 Suppression. OncoTargets and Therapy, 13, 31-44. [Google Scholar] [CrossRef] [PubMed]
[5] Zhang, C., Zhang, Q., Qin, L., Yan, Z., Wu, L. and Liu, T. (2023) Dioscin Ameliorates Experimental Autoimmune Thyroiditis via the mTOR and TLR4/NF-κB Signaling. Drug Design, Development and Therapy, 17, 2273-2285. [Google Scholar] [CrossRef] [PubMed]
[6] Fang, J., Wang, R., Li, X., Wang, X., Gong, L., Lou, A., et al. (2025) Targeting the BMI1-Noxa Axis by Dioscin Induces Apoptosis in Oral Squamous Cell Carcinoma Cells. Journal of Cancer, 16, 110-121. [Google Scholar] [CrossRef] [PubMed]
[7] Ma, T., Ge, X., Zhu, J., Song, C., Wang, P. and Cai, J. (2023) Dioscin Impedes Proliferation, Metastasis and Enhances Autophagy of Gastric Cancer Cells via Regulating the USP8/TGM2 Pathway. Molecular Biotechnology, 66, 3700-3711. [Google Scholar] [CrossRef] [PubMed]
[8] Zhu, X., Du, L., Zhang, L., Ding, L., Xu, W. and Lin, X. (2024) The Critical Role of Toll-Like Receptor 4 in Bone Remodeling of Osteoporosis: From Inflammation Recognition to Immunity. Frontiers in Immunology, 15, Article 1333086. [Google Scholar] [CrossRef] [PubMed]
[9] Kshetrimayum, V., Chanu, K.D., Biona, T., Kar, A., Haldar, P.K., Mukherjee, P.K., et al. (2024) Paris polyphylla sm. Characterized Extract Infused Ointment Accelerates Diabetic Wound Healing in In-Vivo Model. Journal of Ethnopharmacology, 331, Article ID: 118296. [Google Scholar] [CrossRef] [PubMed]
[10] Jia, J., Yang, J., Yang, X., Luo, J., Duan, X., Yang, Y., et al. (2024) Polyhydroxylated Spirostanol Saponins from the Rhizomes of Paris dulongensis. Chemistry & Biodiversity, 21, e202400980. [Google Scholar] [CrossRef] [PubMed]
[11] Huang, J., Jiang, C., Li, T., Hu, Z., Xiang, Q. and Chen, H. (2025) Integrating Experimental and Network Pharmacology to Explore the Pharmacological Mechanisms of Dioscin against Glioblastoma. Open Medicine, 20, Article ID: 20251194. [Google Scholar] [CrossRef] [PubMed]
[12] 张国强, 陆振耀, 王欢, 等. 薯蓣皂苷的脱糖基代谢及其对人结肠癌细胞增殖的影响[J]. 南京中医药大学学报, 2025(4): 494-500.
[13] Cai, J., Liu, M., Wang, Z. and Ju, Y. (2002) Apoptosis Induced by Dioscin in Hela Cells. Biological and Pharmaceutical Bulletin, 25, 193-196. [Google Scholar] [CrossRef] [PubMed]
[14] Chileh-Chelh, T., López-Ruiz, R., García-Cervantes, A.M., Rodríguez-García, I., Rincón-Cervera, M.A., Ezzaitouni, M., et al. (2024) Cytotoxicity and Chemotaxonomic Significance of Saponins from Wild and Cultured Asparagus Shoots. Molecules, 29, Article 3367. [Google Scholar] [CrossRef] [PubMed]
[15] 罗毅. 黄精总皂苷与薯蓣皂苷的提取分离及抗肿瘤活性研究[D]: [硕士学位论文]. 哈尔滨: 哈尔滨商业大学, 2023.
[16] Li, X., Zhang, X., Ma, R., Ni, Z., Thakur, K., Cespedes-Acuña, C.L., et al. (2023) Integrated miRNA and mRNA Omics Reveal Dioscin Suppresses Migration and Invasion via MEK/ERK and JNK Signaling Pathways in Human Endometrial Carcinoma in Vivo and in Vitro. Journal of Ethnopharmacology, 303, Article ID: 116027. [Google Scholar] [CrossRef] [PubMed]
[17] Wang, P., Wang, C. and Liu, C. (2020) Antitumor Effects of Dioscin in A431 Cells via Adjusting ATM/p53-Mediated Cell Apoptosis, DNA Damage and Migration. Oncology Letters, 21, Article No. 59. [Google Scholar] [CrossRef] [PubMed]
[18] Cai, X., Huang, Z., Tu, F. and Yu, J. (2024) Impact and Mechanism Study of Dioscin on Biological Characteristics of Colorectal Cancer Cells. World Journal of Gastrointestinal Oncology, 16, 4456-4467. [Google Scholar] [CrossRef] [PubMed]
[19] Li, M., Zhao, Q., Liao, J., Wang, X., Liu, L., Zhang, X., et al. (2023) Dioscin Inhibiting EGFR-Mediated Survivin Expression Promotes Apoptosis in Oral Squamous Cell Carcinoma Cells. Journal of Cancer, 14, 2027-2038. [Google Scholar] [CrossRef] [PubMed]
[20] Tian, H., Chen, X., Zhang, Y., Wang, Y., Fu, X., Gu, W., et al. (2021) Dioscin Inhibits SCC15 Cell Proliferation via the RASSF1A/MST2/YAP Axis. Molecular Medicine Reports, 23, Article No. 414. [Google Scholar] [CrossRef] [PubMed]
[21] Gulia, S., Chandra, P. and Das, A. (2025) Natural Compound Dioscin Targeting Multiple Cancer Pathways through Its High Affinity Binding to B Cell Lymphoma-2. Current Computer-Aided Drug Design, 21, 609-628. [Google Scholar] [CrossRef] [PubMed]
[22] Wang, Y., Fu, M., Liu, J., Yang, Y., Yu, Y., Li, J., et al. (2019) Inhibition of Tumor Metastasis by Targeted Daunorubicin and Dioscin Codelivery Liposomes Modified with PFV for the Treatment of Non-Small-Cell Lung Cancer. International Journal of Nanomedicine, 14, 4071-4090. [Google Scholar] [CrossRef] [PubMed]
[23] Liu, Y., Xu, B., Chen, Y., Fu, X., Zhu, P., Bai, J., et al. (2020) Inhibiting the Src/STAT3 Signaling Pathway Contributes to the Anti-Melanoma Mechanisms of Dioscin. Oncology Letters, 19, 2508-2514. [Google Scholar] [CrossRef] [PubMed]
[24] Li, X., Ma, R., Ni, Z., Thakur, K., Cespedes-Acuña, C.L., Wang, S., et al. (2021) Dioscin Inhibits Human Endometrial Carcinoma Proliferation via G0/G1 Cell Cycle Arrest and Mitochondrial-Dependent Signaling Pathway. Food and Chemical Toxicology, 148, Article ID: 111941. [Google Scholar] [CrossRef] [PubMed]
[25] Xu, L., Gu, L., Tao, X., Xu, Y., Qi, Y., Yin, L., et al. (2018) Effect of Dioscin on Promoting Liver Regeneration via Activating Notch1/Jagged1 Signal Pathway. Phytomedicine, 38, 107-117. [Google Scholar] [CrossRef] [PubMed]
[26] Yao, H., Xu, Y., Yin, L., Tao, X., Xu, L., Qi, Y., et al. (2017) Dioscin Protects Anit-Induced Intrahepatic Cholestasis through Regulating Transporters, Apoptosis and Oxidative Stress. Frontiers in Pharmacology, 8, Article 116. [Google Scholar] [CrossRef] [PubMed]
[27] Yao, Y., Cui, L., Ye, J., Yang, G., Lu, G., Fang, X., et al. (2020) Dioscin Facilitates Ros-Induced Apoptosis via the P38-MAPK/HSP27-Mediated Pathways in Lung Squamous Cell Carcinoma. International Journal of Biological Sciences, 16, 2883-2894. [Google Scholar] [CrossRef] [PubMed]
[28] Zheng, G., Zhang, Q., Chang, B., Xie, P., Liao, H., Du, S., et al. (2022) Dioscin Induces Osteosarcoma Cell Apoptosis by Upregulating Ros‐mediated P38 MAPK Signaling. Drug Development Research, 84, 25-35. [Google Scholar] [CrossRef] [PubMed]
[29] Guan, L., Mao, Z., Yang, S., Wu, G., Chen, Y., Yin, L., et al. (2022) Dioscin Alleviates Alzheimer’s Disease through Regulating RAGE/NOX4 Mediated Oxidative Stress and Inflammation. Biomedicine & Pharmacotherapy, 152, Article ID: 113248. [Google Scholar] [CrossRef] [PubMed]
[30] Liu, Y., Xu, B., Niu, X., Chen, Y., Fu, X., Wang, X., et al. (2022) Inhibition of Src/STAT3 Signaling-Mediated Angiogenesis Is Involved in the Anti-Melanoma Effects of Dioscin. Pharmacological Research, 175, Article ID: 105983. [Google Scholar] [CrossRef] [PubMed]
[31] Bai, J., Zhang, X., Meng, W., Xu, H., Liu, Y., Zhong, Y., et al. (2024) Dioscin Decreases M2 Polarization via Inhibiting a Positive Feedback Loop between RBM47 and NF-κB in Glioma. Phytomedicine, 128, Article ID: 155417. [Google Scholar] [CrossRef] [PubMed]
[32] Kim, E., Jang, J., Lee, Y., Sung, E., Song, I., Kim, J., et al. (2014) Dioscin Induces Caspase-Independent Apoptosis through Activation of Apoptosis-Inducing Factor in Breast Cancer Cells. Apoptosis, 19, 1165-1175. [Google Scholar] [CrossRef] [PubMed]
[33] Yao, X., Niu, F., Kong, L., Cai, F., Jing, M., Fu, M., et al. (2020) GGP Modified Daunorubicin Plus Dioscin Liposomes Inhibit Breast Cancer by Suppressing Epithelial-Mesenchymal Transition. Drug Development and Industrial Pharmacy, 46, 916-930. [Google Scholar] [CrossRef] [PubMed]
[34] Ock, C.W. and Kim, G.D. (2021) Dioscin Decreases Breast Cancer Stem-Like Cell Proliferation via Cell Cycle Arrest by Modulating P38 Mitogen-Activated Protein Kinase and Akt/mTOR Signaling Pathways. Journal of Cancer Prevention, 26, 183-194. [Google Scholar] [CrossRef] [PubMed]
[35] 曲红琰, 吴沛柔, 叶奕含, 等. 薯蓣皂苷通过STAT3信号通路发挥抗非小细胞肺癌的作用[J]. 温州医科大学学报, 2025: 1-15.
http://kns.cnki.net/kcms/detail/33.1386.R.20250606.0917.014.html, 2025-06-26.
[36] Mao, W., Yin, H., Chen, W., Zhao, T., Wu, S., Jin, H., et al. (2020) Network Pharmacology and Experimental Evidence Reveal Dioscin Suppresses Proliferation, Invasion, and EMT via AKT/GSK3b/mTOR Signaling in Lung Adenocarcinoma. Drug Design, Development and Therapy, 14, 2135-2147. [Google Scholar] [CrossRef] [PubMed]
[37] Wang, R., Li, X., Gan, Y., Liao, J., Han, S., Li, W., et al. (2024) Dioscin Inhibits Non-Small Cell Lung Cancer Cells and Activates Apoptosis by Downregulation of Survivin. Journal of Cancer, 15, 1366-1377. [Google Scholar] [CrossRef] [PubMed]
[38] Kong, L., Zhang, S., Chu, J., Liu, X., Zhang, L., He, S., et al. (2020) Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC. International Journal of Nanomedicine, 15, 6451-6468. [Google Scholar] [CrossRef] [PubMed]
[39] Li, R., Qin, J., Wang, Z., Lv, F., Guo, J., Zhu, H., et al. (2023) Dioscin Reduced Chemoresistance for Colon Cancer and Analysis of Sensitizing Targets. Biochemical and Biophysical Research Communications, 638, 94-102. [Google Scholar] [CrossRef] [PubMed]
[40] Zhou, L., Yu, X., Li, M., Gong, G., Liu, W., Li, T., et al. (2020) CDH1-Mediated Skp2 Degradation by Dioscin Reprogrammes Aerobic Glycolysis and Inhibits Colorectal Cancer Cells Growth. EBioMedicine, 51, Article ID: 102570. [Google Scholar] [CrossRef] [PubMed]
[41] Wang, X., Yu, P. and Li, J. (2020) High-Throughput Metabolomics for Identification of Metabolic Pathways and Deciphering the Effect Mechanism of Dioscin on Rectal Cancer from Cell Metabolic Profiles Coupled with Chemometrics Analysis. Frontiers in Pharmacology, 11, Article 68. [Google Scholar] [CrossRef] [PubMed]
[42] Xun, J., Zhou, S., Lv, Z., Wang, B., Luo, H., Zhang, L., et al. (2023) Dioscin Modulates Macrophages Polarization and MDSCs Differentiation to Inhibit Tumorigenesis of Colitis-Associated Colorectal Cancer. International Immunopharmacology, 117, Article ID: 109839. [Google Scholar] [CrossRef] [PubMed]
[43] Okubo, S., Ohta, T., Shoyama, Y. and Uto, T. (2021) Steroidal Saponins Isolated from the Rhizome of Dioscorea tokoro Inhibit Cell Growth and Autophagy in Hepatocellular Carcinoma Cells. Life, 11, Article 749. [Google Scholar] [CrossRef] [PubMed]
[44] Jin, S., Guan, T., Wang, S., Hu, M., Liu, X., Huang, S., et al. (2022) Dioscin Alleviates Cisplatin-Induced Mucositis in Rats by Modulating Gut Microbiota, Enhancing Intestinal Barrier Function and Attenuating TLR4/NF-κB Signaling Cascade. International Journal of Molecular Sciences, 23, Article 4431. [Google Scholar] [CrossRef] [PubMed]
[45] Jin, S., Zhu, T., Deng, S., Li, D., Li, J., Liu, X., et al. (2022) Dioscin Ameliorates Cisplatin-Induced Intestinal Toxicity by Mitigating Oxidative Stress and Inflammation. International Immunopharmacology, 111, Article ID: 109111. [Google Scholar] [CrossRef] [PubMed]
[46] Xie, Y. and Chen, G. (2021) Dioscin Induces Ferroptosis and Synergistic Cytotoxicity with Chemotherapeutics in Melanoma Cells. Biochemical and Biophysical Research Communications, 557, 213-220. [Google Scholar] [CrossRef] [PubMed]
[47] Wang, H., Zhu, H. and Yang, X. (2020) Dioscin Exhibits Anti-Inflammatory Effects in Il-1β-Stimulated Human Osteoarthritis Chondrocytes by Activating LXRα. Immunopharmacology and Immunotoxicology, 42, 340-345. [Google Scholar] [CrossRef] [PubMed]
[48] Shao, Q., Jiang, C., Xia, Y., et al. (2019) Dioscin Ameliorates Peritoneal Fibrosis by Inhibiting Epithelial-to-Mesenchymal Transition of Human Peritoneal Mesothelial Cells via the TLR4/MyD88/NF-κB Signaling Pathway. International Journal of Clinical and Experimental Pathology, 12, 867-875.
[49] Ye, P., Wang, Q., Liu, C., Li, G., Olatunji, O.J., Lin, J., et al. (2024) SIRT1 Inhibitors within Qing-Luo-Yin Alleviated White Adipose Tissues-Mediated Inflammation in Antigen-Induced Arthritis Mice. Phytomedicine, 122, Article ID: 155132. [Google Scholar] [CrossRef] [PubMed]
[50] Jiang, W., Lin, M. and Wang, Z. (2020) Dioscin: A New Potential Inhibitor of SKP2 for Cancer Therapy. EBioMedicine, 51, Article ID: 102593. [Google Scholar] [CrossRef] [PubMed]
[51] Shi, L., Zhang, P., Jin, R., Chen, X., Dong, L. and Chen, W. (2022) Dioscin Ameliorates Inflammatory Bowel Disease by Up‐Regulating miR‐125a‐5p to Regulate Macrophage Polarization. Journal of Clinical Laboratory Analysis, 36, e24455. [Google Scholar] [CrossRef] [PubMed]
[52] Wang, D. and Wang, X. (2022) Diosgenin and Its Analogs: Potential Protective Agents against Atherosclerosis. Drug Design, Development and Therapy, 16, 2305-2323. [Google Scholar] [CrossRef] [PubMed]
[53] Wang, D., Sha, L., Xu, C., Huang, Y., Tang, C., Xu, T., et al. (2022) Natural Saponin and Cholesterol Assembled Nanostructures as the Promising Delivery Method for Saponin. Colloids and Surfaces B: Biointerfaces, 214, Article ID: 112448. [Google Scholar] [CrossRef] [PubMed]
[54] Bandopadhyay, S., Anand, U., Gadekar, V.S., Jha, N.K., Gupta, P.K., Behl, T., et al. (2021) Dioscin: A Review on Pharmacological Properties and Therapeutic Values. BioFactors, 48, 22-55. [Google Scholar] [CrossRef] [PubMed]
[55] Wang, S., Fu, J., Hao, H., Jiao, Y., Li, P. and Han, S. (2021) Metabolic Reprogramming by Traditional Chinese Medicine and Its Role in Effective Cancer Therapy. Pharmacological Research, 170, Article ID: 105728. [Google Scholar] [CrossRef] [PubMed]